Clinical Trials Browser

Solid Tumor × nimotuzumab × Other solid neoplasm × Clear all

NCT06022276 2023-09-01

Nimotuzumab for EGFR-amplified Advanced Pan Solid Tumors

Phase NA Unknown

Other solid neoplasm

Solid Tumor